Detalhe da pesquisa
1.
'High hopes for treatment': Australian stakeholder perspectives of the clinical translation of advanced neurotherapeutics for rare neurological diseases.
Health Expect
; 27(3): e14063, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711219
2.
'Advocacy groups are the connectors': Experiences and contributions of rare disease patient organization leaders in advanced neurotherapeutics.
Health Expect
; 25(6): 3175-3191, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36307981
3.
Taurine deficiency as a driver of aging.
Science
; 380(6649): eabn9257, 2023 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37289866
4.
Conserved multi-tissue transcriptomic adaptations to exercise training in humans and mice.
Cell Rep
; 42(5): 112499, 2023 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37178122
5.
The involvement of rare disease patient organisations in therapeutic innovation across rare paediatric neurological conditions: a narrative review.
Orphanet J Rare Dis
; 17(1): 167, 2022 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35436886
6.
Effect of voluntary exercise upon the metabolic syndrome and gut microbiome composition in mice.
Physiol Rep
; 9(21): e15068, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34755487
7.
Mitochondrial Dysfunction Is an Early Consequence of Partial or Complete Dystrophin Loss in mdx Mice.
Front Physiol
; 11: 690, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32636760